Dr Reddys Laboratories Ltd (RDY) income statement
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.89+0.06 (+0.40%)
Close on Nov 20, 2026Market cap $12.43BP/E 27.3Yield 0.57%
Dr Reddys Laboratories Ltd financial ratios
See a number that looks wrong?